menu search

Gold moves higher; outlook therapeutics shares plummet

In commodity news, oil traded down 0.1% to $81.08 while gold traded up 0.5% at $1,974.60 … fell for the fourth straight month to 93.3 in August. The...

August 30, 2023, 5:02 pm

Outlook therapeutics® provides regulatory update on fda review of ons-5010 / lytenava™ (bevacizumab-vikg) for the treatment of wet amd

FDA issues Complete Response Letter (CRL) for ONS-5010 BLA based on CMC and need for further confirmatory clinical evidence Out...

August 30, 2023, 10:00 am

Why is outlook therapeutics (otlk) stock down 78% today?

Outlook therapeutics (NASDAQ: OTLK ) stock is taking a beating on Wednesday after getting a rejection ...

August 30, 2023, 8:16 am

Outlook therapeutics collapses as fda rejects application for eye drug

Outlook therapeutics Inc (NASDAQ:OTLK) stock collapsed, losing some 70% of its value in premarket, afte...

August 30, 2023, 7:16 am

Us fda declines to approve outlook therapeutics' eye disease drug

Outlook therapeutics said on Wednesday the U.S. Food and Drug Administration declined to approve its ex...

August 30, 2023, 6:35 am

Outlook therapeutics' stock tumbles 71% premarket after fda rejects treatment for wet amd

Outlook therapeutics Inc.'s stock OTLK, +10.16% tumbled 71% in premarket trade Wednesday, after the com...

August 30, 2023, 6:29 am

Cmc markets lowers fy24 outlook, shares tumble

CMC Markets (LON: CMCX) has released a trading update today (Friday), revealing its expectations of a lower net operating income between £250 and £2...

August 25, 2023, 8:07 am

Should you buy outlook therapeutics (otlk) ahead of earnings?

Outlook therapeutics (OTLK) is seeing favorable earnings estimate revision activity and has a positive ...

August 14, 2023, 11:39 am

3 auto stocks to buy for growth & value

Investors will not want to overlook these automakers as their growth stories and valuations are very at...

August 10, 2023, 6:16 pm

Don't overlook these affordable stocks as earnings approach

Components such as valuation, growth, and rising earnings estimates help reconfirm it's time to buy these top-rated stocks for their affordable prices...

August 8, 2023, 9:11 pm

Meta beat expectations, but investors shouldn't overlook these 2 concerning numbers

Reality Labs' multibillion losses aren't going away anytime soon. Meta's growth rate hasn't been that strong in recent quarters....

August 4, 2023, 4:15 pm

Outlook therapeutics® to present at the btig virtual biotechnology conference 2023

ISELIN, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Outlook therapeutics, Inc. (Nasdaq: OTLK), a biopharma...

August 1, 2023, 8:45 am

On semiconductor q2 earnings: ‘bigger trends are in our favour'

ON Semiconductor Corp (NASDAQ: ON) is in focus on Monday after reporting its financial results for the second quarter that handily topped Street estim...

July 31, 2023, 3:34 pm

With q2 earnings underway, keep an eye on the overnight session

Investors shouldn't overlook the overnight trading session, especially as earnings season gets into ful...

July 17, 2023, 6:43 pm

Don't overlook these top-rated stocks it's time to buy

Arcos Dorados (ARCO), Atlantica Sustainable Infrastructure (AY), and Lyft (LYFT) are very relevant companies in their respective industries and have t...

July 12, 2023, 9:35 pm

2 ai stocks that are screaming buys in july

Investors shouldn't overlook the role that data services will play in pushing AI forward. Artificial in...

July 12, 2023, 5:15 am

3 reasons pepsico stock is a buy

Sales in the latest quarter were up at a double-digit rate. Management has been cutting costs and raising its earnings out...

July 5, 2023, 9:45 am

Great time to own these reits - brad thomas with kirk spano

Brad Thomas talks to Kirk Spano about REITs and real estate investing. Are industrial REITs underappreciated and which US regions ...

June 26, 2023, 7:15 am

Don't overlook these consumer-centric stocks it's time to buy

With these consumer-centric stocks standing out in terms of value now appears to be a good time to buy as global economic conditions stabilize and inf...

June 14, 2023, 9:45 pm

Outlook therapeutics: august pdufa may be a buy with some caveats

OTLK is developing an ophthalmic formulation of bevacizumab. There is a logic behind this, and there's also positive data. However, certain developmen...

June 10, 2023, 1:06 am


Search within

Pages Search Results: